Literature DB >> 11074184

Ketamine controls prolonged status epilepticus.

D J Borris1, E H Bertram, J Kapur.   

Abstract

New treatments are needed to control prolonged status epilepticus given the high failure rate of current therapies. In an animal model of status epilepticus based on electrical stimulation of the hippocampus, rats demonstrate at least 5 five-hours of seizure activity following stimulation. Phenobarbital (70 mg/kg) administered 15 min after stimulation effectively controlled seizures in 66% of animals (n=6). When phenobarbital (70 mg/kg) was administered 60 min after stimulation, seizures were controlled in 25% of animals (n=4). Ketamine (100 mg/kg) administered 15 min after stimulation did not control seizures in any animal (n=4). But when ketamine was administered one hour after stimulation it effectively controlled seizures in all animals (n=4). Increasing doses of ketamine were administered 60 min after stimulation to generate a dose-response curve. The ketamine dose response (fraction of seizure free rats) data were fit to a sigmoid curve to derive an ED(50) of 58 mg/kg. These findings suggest that prolonged status epilepticus becomes refractory to phenobarbital but can be effectively controlled by ketamine. For patients experiencing prolonged status epilepticus that is refractory to phenobarbital, ketamine may be an alternative to general anesthesia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074184      PMCID: PMC2885610          DOI: 10.1016/s0920-1211(00)00175-3

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  25 in total

1.  Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam.

Authors:  N Y Walton; D M Treiman
Journal:  Brain Res       Date:  1991-07-05       Impact factor: 3.252

2.  Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.

Authors:  D B Clifford; J W Olney; A M Benz; T A Fuller; C F Zorumski
Journal:  Epilepsia       Date:  1990 Jul-Aug       Impact factor: 5.864

3.  NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants.

Authors:  E H Bertram; E W Lothman
Journal:  Epilepsy Res       Date:  1990-04       Impact factor: 3.045

4.  The effect of MK-801 on kindled seizures: implications for use and limitations as an antiepileptic drug.

Authors:  J M Williamson; E W Lothman
Journal:  Ann Neurol       Date:  1989-07       Impact factor: 10.422

5.  Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist.

Authors:  R G Fariello; G T Golden; G G Smith; P F Reyes
Journal:  Epilepsy Res       Date:  1989 May-Jun       Impact factor: 3.045

6.  Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus.

Authors:  K Yaffe; D H Lowenstein
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

7.  Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

Authors:  A M Mazarati; R A Baldwin; R Sankar; C G Wasterlain
Journal:  Brain Res       Date:  1998-12-14       Impact factor: 3.252

Review 8.  Pathophysiological mechanisms of brain damage from status epilepticus.

Authors:  C G Wasterlain; D G Fujikawa; L Penix; R Sankar
Journal:  Epilepsia       Date:  1993       Impact factor: 5.864

9.  Hippocampal pyramidal cell loss in human status epilepticus.

Authors:  C M DeGiorgio; U Tomiyasu; P S Gott; D M Treiman
Journal:  Epilepsia       Date:  1992 Jan-Feb       Impact factor: 5.864

10.  A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus.

Authors:  D M Treiman; N Y Walton; C Kendrick
Journal:  Epilepsy Res       Date:  1990 Jan-Feb       Impact factor: 3.045

View more
  41 in total

Review 1.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

2.  Ketamine for Refractory Status Epilepticus: A Systematic Review.

Authors:  Anna Rosati; Salvatore De Masi; Renzo Guerrini
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

Review 3.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

4.  N-methyl-D-aspartic acid receptor activation downregulates expression of δ subunit-containing GABAA receptors in cultured hippocampal neurons.

Authors:  Suchitra Joshi; Jaideep Kapur
Journal:  Mol Pharmacol       Date:  2013-04-12       Impact factor: 4.436

5.  Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus.

Authors:  David E Naylor; Hantao Liu; Jerome Niquet; Claude G Wasterlain
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

6.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

7.  The electrocortical effects of enflurane: experiment and theory.

Authors:  James W Sleigh; Jeannette A Vizuete; Logan Voss; Alistair Steyn-Ross; Moira Steyn-Ross; Charles J Marcuccilli; Anthony G Hudetz
Journal:  Anesth Analg       Date:  2009-10       Impact factor: 5.108

8.  Ketamine for medically refractory status epilepticus after elective aneurysm clipping.

Authors:  F A Zeiler; A M Kaufmann; L M Gillman; M West; J Silvaggio
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

9.  A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.

Authors:  Weiwei Yen; John Williamson; Edward H Bertram; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2004-03       Impact factor: 3.045

10.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.